Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dapagliflozin Attenuates HFpEF Remodeling and Dysfunction by Elevating β-Hydroxybutyrate-activated Citrate Synthase
Xinxin Zhang, Ning Wang, Peng Fu, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 82, Iss. 5, pp. 375-388
Open Access | Times Cited: 18

Showing 18 citing articles:

Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 8
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
Rosalinda Madonna, Filippo Biondi, Mattia Alberti, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116650-116650
Open Access | Times Cited: 5
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension
Justin H. Berger, Yuji Shi, Timothy Matsuura, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Growth Differentiation Factor 15 Inhibits Cardiac Fibrosis, Oxidative Stress, Inflammation, and Apoptosis in a Rat Model of Heart Failure with Preserved Ejection Fraction
Xuyang Meng, Yi Li, Ling‐bing Meng, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 2
Open Access
The Role of Mitophagy in Cardiac Metabolic Remodeling of Heart Failure: Insights of Molecular Mechanisms and Therapeutic Prospects
Fangying Yan, Liwen Bao
Journal of Cardiovascular Translational Research (2025)
Closed Access
Transcutaneous Auricular Vagus Nerve Stimulation Ameliorates Heart Failure with Preserved Ejection Fraction Through Regulating Macrophage Polarization Mediated by Alpha7nAChR
Junyu Huo, Can Hou, Fang Jia, et al.
Cardiovascular Drugs and Therapy (2025)
Closed Access
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure
Elena Conte, Paola Imbrici, Giorgia Dinoi, et al.
European Journal of Pharmacology (2025), pp. 177617-177617
Open Access
Adenosine triphosphate-induced cell death in heart failure: Is there a link?
Jingjing Zhang, Lu Cheng, Qian Qiao, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 4
Closed Access
The landscape of novel antidiabetic drugs in diabetic HFpEF: relevant mechanisms and clinical implications
Xiaohui Duan, Xiaomeng Zhang, Bao Sun
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Differential Modulation of Catecholamine and Adipokine Secretion by the Short Chain Fatty Acid Receptor FFAR3 and α2-Adrenergic Receptors in PC12 Cells
Deepika Nagliya, Teresa Baggio Lopez, Giselle Del Calvo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 2
The total xanthones extracted from Gentianella acuta alleviates HFpEF by activating the IRE1α/Xbp1s pathway
Linna Zhao, Yi-Ping Qin, Yangong Liu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 11
Open Access | Times Cited: 1
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension
Justin H. Berger, Yuji Shi, Timothy Matsuura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?
Jonathan Elliott, Mark A. Oyama
Journal of Veterinary Pharmacology and Therapeutics (2024)
Open Access | Times Cited: 1
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction
Alberto Palazzuoli, Paolo Severino, Andrea D’Amato, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access | Times Cited: 1
β-Hydroxybutyrate and Citrate Synthase as Potential Diagnostic Biomarkers in Aging-Related Atrial Fibrillation
Jiakang He, Xiaoxiao Jiang, Shiyu Dai, et al.
Journal of Cardiovascular Translational Research (2024) Vol. 18, Iss. 1, pp. 133-145
Open Access | Times Cited: 1
RGS Proteins in Sympathetic Nervous System Regulation: Focus on Adrenal RGS4
Anastasios Lymperopoulos, Renee A. Stoicovy
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 10
Open Access
Exogenous Ketones in Cardiovascular Disease and Diabetes: From Bench to Bedside
Urna Kansakar, Crystal Nieves Garcia, Gaetano Santulli, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7391-7391
Open Access
Beyond ketosis: the search for the mechanism underlying SGLT2-inhibitor benefit continues
Justin H. Berger, Brian N. Finck
Journal of Clinical Investigation (2024) Vol. 134, Iss. 24
Open Access
Effect of dapagliflozin on the serum metabolome in patients with type 2 diabetes mellitus
Sempastian Filippas-Ntekouan, Aikaterini Dimou, Panagiotis Dafopoulos, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 24, Iss. 1
Closed Access
Page 1

Scroll to top